Chronic prostatitis
Conditions
Interventions
Group 1:Guilong Dan Granules
Group 2:Qianlie Shutong Capsules
Sponsors
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the NIH-CPSI criteria for Western medicine diagnosis; (NIH-CPSI = 15 points); (2) Those who meet the standards of traditional Chinese medicine for chronic prostatitis with damp heat and stasis obstruction; (3) Between the ages of 18 and 50; (4) The course of the disease is = 3 months; (5) Patients who have already undergone treatment before seeking medical attention can only be included after stopping medication for at least 2 weeks; (6) Voluntarily participate in treatment and sign an informed consent form for the trial.
Exclusion criteria
Exclusion criteria: (1) Combine benign prostate obstruction, prostate cancer, neurogenic bladder, urethral deformity or stenosis, urinary calculi, urinary tract infection, severe neurosis and other diseases affecting urination; (2) Diseases that cause pain in the perineal region due to the combination of prostate abscess, inguinal hernia, pubic inflammation, varicocele, epididymitis, and rectal colon disease; (3) Ever received prostate surgery or laser, radiofrequency, microwave, ablation therapy; (4) Primary diseases such as cardiovascular disease, hematopoietic system disease, liver and kidney dysfunction; (5) Serious diabetes, mental illness and other serious diseases; (6) Allergic constitution or allergy to multiple drugs; (7) Patients with anxiety, depression (Self-Rating Anxiety Scale and Depression Scale) or neurological disorders who cannot express their will, have difficulty moving, or cannot cooperate with treatment and examination; (8) Those who have serious tobacco and alcohol addictions (unable to control their smoking and drinking habits, and experiencing hand tremors, palpitations, and anxiety when not smoking or drinking) and drug addiction that affect their daily lives; (9) Patients who participated in other clinical trials within one month; (10) Patients taking drugs that affect the metabolism of this drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH chronic prostatitis symptom index,NIH-CPSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| NIH-CPSI three sub scores, including pain or discomfort score, urinary symptom score, and quality of life score);Quantitative grading of traditional Chinese medicine symptoms;Prostate specialist examination score;SAS-SDS; | — |
Countries
China
Contacts
Public ContactHuang Yuhong
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed